speb/financial-data huggingface dataset:
SMSN.L income_statement (annual, 2025-12-31) — Net Interest Income: 3987311000000.00
SMSN.L income_statement (quarterly, 2025-12-31) — Net Interest Income: 965075000000.00
SMSN.L cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -14986356000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -17892400000000.00
SMSN.L cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 4609379000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 7950005000000.00
SMSN.L cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -45970000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -46991000000.00
SMSN.L income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 3987311000000.00
SMSN.L income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 965075000000.00
SMSN.L cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -973000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 1412000000.00
SMSN.L cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 1495866000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 1764487000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Net PPE: 215304784000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Net PPE: 215304784000000.00
SMSN.L cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -47372351000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -11569637000000.00
SMSN.L cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 4655349000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 7996996000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 394832690000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 394832690000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 18840559000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 18840559000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 709226000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 709226000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 558520000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 558520000000.00
SMSN.L income_statement (annual, 2025-12-31) — Normalized EBITDA: 96664037000000.00
SMSN.L income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 33479214000000.00
SMSN.L income_statement (annual, 2025-12-31) — Normalized Income: 43941366728891.93
SMSN.L income_statement (quarterly, 2025-12-31) — Normalized Income: 19342247944345.36
SMSN.L cash_flow (annual, 2025-12-31) — Operating Cash Flow: 85315148000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 28799652000000.00
SMSN.L income_statement (annual, 2025-12-31) — Operating Income: 43601051000000.00
SMSN.L income_statement (quarterly, 2025-12-31) — Operating Income: 20073660000000.00
SMSN.L income_statement (annual, 2025-12-31) — Operating Revenue: 333605938000000.00
SMSN.L income_statement (quarterly, 2025-12-31) — Operating Revenue: 93837371000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 6630180138.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 6630180138.00
SMSN.L balance_sheet (annual, 2025-12-31) — Other Current Assets: 6964529000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 6964529000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 2883176000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 2883176000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Other Equity Interest: 365810000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 365810000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 18375332000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 18375332000000.00
SMSN.L cash_flow (annual, 2025-12-31) — Other Non Cash Items: -3314573000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -171536000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 18719529000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 18719529000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 7953586000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 7953586000000.00
SMSN.L income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 721394000000.00
SMSN.L income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -38290000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Other Payable: 21365657000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Other Payable: 21365657000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Other Properties: 16699750000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Other Properties: 16699750000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Other Receivables: 7481327000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Other Receivables: 7481327000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 67990736000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 67990736000000.00
SMSN.L income_statement (annual, 2025-12-31) — Other Special Charges: 153184000000.00
SMSN.L income_statement (quarterly, 2025-12-31) — Other Special Charges: 88952000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Payables: 41442211000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Payables: 41442211000000.00
SMSN.L cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: 1798189000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Pension And Employee Benefit Expense: 595374000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Preferred Shares Number: 802371203.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Preferred Shares Number: 802371203.00
SMSN.L balance_sheet (annual, 2025-12-31) — Preferred Stock: 119467000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 119467000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 119467000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 119467000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Prepaid Assets: 3627172000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 3627172000000.00
SMSN.L income_statement (annual, 2025-12-31) — Pretax Income: 49481471000000.00
SMSN.L income_statement (quarterly, 2025-12-31) — Pretax Income: 21028203000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Properties: 0.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
SMSN.L cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 144508000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 101294000000.00
SMSN.L cash_flow (annual, 2025-12-31) — Purchase Of Business: -3456685000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -2503889000000.00
SMSN.L cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -4630970000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -1210202000000.00
SMSN.L cash_flow (annual, 2025-12-31) — Purchase Of Investment: -20511116000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -15500939000000.00
SMSN.L cash_flow (annual, 2025-12-31) — Purchase Of PPE: -47522179000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -11549288000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Raw Materials: 16411422000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Raw Materials: 16411422000000.00
SMSN.L income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 202235513000000.00
SMSN.L income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 49586396000000.00
SMSN.L income_statement (annual, 2025-12-31) — Reconciled Depreciation: 46926592000000.00
SMSN.L income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 12232032000000.00
SMSN.L cash_flow (annual, 2025-12-31) — Repayment Of Debt: -2852971000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 2491401000000.00
SMSN.L cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -8189263000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -39968000000.00
SMSN.L income_statement (annual, 2025-12-31) — Research And Development: 37740392000000.00
SMSN.L income_statement (quarterly, 2025-12-31) — Research And Development: 10864311000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Retained Earnings: 402135600000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 402135600000000.00
SMSN.L cash_flow (annual, 2025-12-31) — Sale Of Business: 424736000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Sale Of Business: 420613000000.00
SMSN.L cash_flow (annual, 2025-12-31) — Sale Of Intangibles: 13554000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Sale Of Intangibles: 0.00
SMSN.L cash_flow (annual, 2025-12-31) — Sale Of Investment: 5524760000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Sale Of Investment: -2391461000000.00
SMSN.L cash_flow (annual, 2025-12-31) — Sale Of PPE: 149828000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Sale Of PPE: -20349000000.00
SMSN.L income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 30228345000000.00
SMSN.L income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 7547604000000.00
SMSN.L income_statement (annual, 2025-12-31) — Selling General And Administration: 37849252000000.00
SMSN.L income_statement (quarterly, 2025-12-31) — Selling General And Administration: 9910391000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Share Issued: 6735612586.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Share Issued: 6735612586.00
SMSN.L cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 4655349000000.00
SMSN.L income_statement (annual, 2025-12-31) — Special Income Charges: -153184000000.00
SMSN.L income_statement (quarterly, 2025-12-31) — Special Income Charges: -88952000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Stockholders Equity: 424313255000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 424313255000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Tangible Book Value: 394713223000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 394713223000000.00
SMSN.L income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 30219728891.93
SMSN.L income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -3543055654.64
SMSN.L income_statement (annual, 2025-12-31) — Tax Provision: 4274666000000.00
SMSN.L income_statement (quarterly, 2025-12-31) — Tax Provision: 1386458000000.00
SMSN.L income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.09
SMSN.L income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.07
SMSN.L cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -7137295000000.00
SMSN.L cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -2172220000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Total Assets: 566942110000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Total Assets: 566942110000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Total Capitalization: 427126403000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 427126403000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Total Debt: 25239139000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Total Debt: 25239139000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 436320337000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 436320337000000.00
SMSN.L income_statement (annual, 2025-12-31) — Total Expenses: 290004887000000.00
SMSN.L income_statement (quarterly, 2025-12-31) — Total Expenses: 73763711000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 130621773000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 130621773000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 319257498000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 319257498000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 24210425000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 24210425000000.00
SMSN.L income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 43601051000000.00
SMSN.L income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 20073660000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Total Tax Payable: 7037174000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 7037174000000.00
SMSN.L income_statement (annual, 2025-12-31) — Total Unusual Items: 349809000000.00
SMSN.L income_statement (quarterly, 2025-12-31) — Total Unusual Items: -53737000000.00
SMSN.L income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 349809000000.00
SMSN.L income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -53737000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 5602031000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 5602031000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 196845605.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 196845605.00
SMSN.L balance_sheet (annual, 2025-12-31) — Treasury Stock: 6606360000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 6606360000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Work In Process: 26775342000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Work In Process: 26775342000000.00
SMSN.L balance_sheet (annual, 2025-12-31) — Working Capital: 141273264000000.00
SMSN.L balance_sheet (quarterly, 2025-12-31) — Working Capital: 141273264000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — +Operating Expense: 24680376000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — +Total Revenue: 133873444000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 15820977000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 82285029000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 4403893000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Amortization: 232432000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 886407000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 22090048000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Basic Average Shares: 232395440.00
SMSN.L income_statement (quarterly, 2026-03-31) — Basic EPS: 178075.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 57856378000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -18176955000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 4968799000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Capital Stock: 897514000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 73306751000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 147378074000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -13824000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 73306751000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -3004248000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Change In Inventory: -4115133000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 735543000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Change In Payable: 1233311000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -97096000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Change In Receivables: -28641618000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -32009049000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Changes In Cash: 13362838000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Common Stock: 778047000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 473845334000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -7614808000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 51960271000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Current Assets: 306220075000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1181069000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Current Debt: 19556414000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 20737483000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 120603778000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Current Provisions: 10066410000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Deferred Tax: 11603162000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Defined Pension Benefit: 3310596000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Depreciation: 11480235000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 12366642000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 694581000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 462149000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 234904040.00
SMSN.L income_statement (quarterly, 2026-03-31) — Diluted EPS: 176400.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Dividend Received Cfo: 28211000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — EBIT: 59106103000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — EBITDA: 71472745000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 2087535000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — End Cash Position: 73306751000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1374329000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -5455268000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Finished Goods: 16591707000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 22097151000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -35688000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 37702000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1964363000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 29643717000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 82285029000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Gross PPE: 217814922000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Gross Profit: 81913173000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Interest Expense: 277669000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 277669000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Interest Income: 1228109000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1228109000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Interest Paid Cfo: -148289000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Interest Received Cfo: 931109000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Inventories Adjustments Allowances: -5262297000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Inventory: 58278373000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Invested Capital: 497015329000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -21456000000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 23464377000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Investments In Other Ventures Under Equity Method: 14102039000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 2518405000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 3787730000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 3613581000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 7401311000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 800505000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -351604000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 14102039000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 3475487000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Minority Interest: 12671175000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Minority Interests: -124082000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 6400000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -7614808000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Net Income: 47101190000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 47101190000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 47225272000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 47101190000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 47101190000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 47225272000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 47225272000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: -1049142000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Net Interest Income: 950440000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -4755679000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 2166801000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 448901000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 950440000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 6563000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 1412275000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Net PPE: 217814922000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -17069854000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 1717900000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 444321084000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 16913148000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 833873000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 614865000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 71511290000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Normalized Income: 47132132487934.32
SMSN.L cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 40274106000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Operating Income: 57232797000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Operating Revenue: 133873444000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 5792563304.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 7523459000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 2892637000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 815205000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 29643717000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 812215000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 21870730000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 8834054000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 123902000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Other Payable: 21242667000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Other Properties: 217814922000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Other Receivables: 6657255000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 74071323000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Other Special Charges: 73434000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Payables: 52292721000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Pension And Employee Benefit Expense: 1342821000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Preferred Shares Number: 802371203.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 119467000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 119467000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 4097885000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Pretax Income: 58828434000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 55308000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: -1049952000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -5509715000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -17127003000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Raw Materials: 19500848000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 51960271000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 12366642000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -351604000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -7614808000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Research And Development: 11336713000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 445609819000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Sale Of Business: 6400000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Sale Of Intangibles: 810000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 754036000000.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 57149000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 7713068000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Selling General And Administration: 9677431000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Share Issued: 5856482069.00
SMSN.L cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 1717900000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Special Income Charges: -73434000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 473964801000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 444201617000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -7602512065.68
SMSN.L income_statement (quarterly, 2026-03-31) — Tax Provision: 11603162000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.20
SMSN.L cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -1476288000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Total Assets: 633339604000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 477578382000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Total Debt: 28138794000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 486635976000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Total Expenses: 76640647000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 146703628000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 327119529000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 26099850000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 57232797000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: -1264723000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 15229077000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Total Unusual Items: -38545000000.00
SMSN.L income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -38545000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 4940260000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 127074618.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 13114994000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Work In Process: 27448115000000.00
SMSN.L balance_sheet (quarterly, 2026-03-31) — Working Capital: 185616297000000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -1296093000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 713684000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -1049000.00
SMSPHARMA.NS income_statement (annual, 2022-03-31) — Amortization: 7100000.00
SMSPHARMA.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 7100000.00
SMSPHARMA.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 84652000.00
SMSPHARMA.NS income_statement (annual, 2022-03-31) — Basic EPS: 7.35
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 1300471000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 31548000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 120000000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 345828000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 10404000.00
SMSPHARMA.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 84652000.00
SMSPHARMA.NS income_statement (annual, 2022-03-31) — Diluted EPS: 7.35
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 773000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 614238000.00
SMSPHARMA.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -20000.00
SMSPHARMA.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 49476000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 486242000.00
SMSPHARMA.NS income_statement (annual, 2022-03-31) — Interest Income: 5596000.00
SMSPHARMA.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 5596000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 215271000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 42130000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 21144000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 215271000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 4187822000.00
SMSPHARMA.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: -1000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 15662000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 50225000.00
SMSPHARMA.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 13701000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 7467000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Other Payable: 69413000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 35322000.00
SMSPHARMA.NS income_statement (annual, 2022-03-31) — Other Special Charges: 37000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 10164000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 113675000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
SMSPHARMA.NS cash_flow (annual, 2022-03-31) — Provisionand Write Offof Assets: 0.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 699815000.00
SMSPHARMA.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 939000.00
SMSPHARMA.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 939000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 773000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 2974122000.00
SMSPHARMA.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 34209000.00
SMSPHARMA.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 83685000.00
SMSPHARMA.NS cash_flow (annual, 2022-03-31) — Short Term Debt Payments: -38353000.00
SMSPHARMA.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 10073000.00
SMSPHARMA.NS balance_sheet (annual, 2022-03-31) — Work In Process: 1189455000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — +Operating Expense: 1066577000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — +Total Revenue: 5197468000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 1074297000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 1483462000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -1601670000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 713684000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -1049000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Amortization: 7087000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 7087000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 181431000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 84652000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Basic EPS: -0.83
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 465828000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 1307811000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -299207000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 15535000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 84652000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 73078000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 73778000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -25396000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 700000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 73078000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 275981000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -4752000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -43134000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Payable: 424373000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Prepaid Assets: 32907000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -998269000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -312894000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -392750000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Common Stock: 84652000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 4605252000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 0.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 388009000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 3906077000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Assets: 4106486000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 9399000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Debt: 1313801000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 1323200000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 2549135000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 10420000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Depreciation: 314167000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 321254000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 321254000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 314167000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 84652000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Diluted EPS: -0.83
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -70593000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 918000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — EBIT: 263435000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — EBITDA: 584689000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — End Cash Position: 73778000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -319689000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 383826000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -74707000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: 544000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 54979000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 14656000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 1484511000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 6095198000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Gross Profit: 1291391000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Interest Expense: 209944000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 209944000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Interest Income: 7748000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 7748000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -209276000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 1581000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Inventory: 2234994000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 7130386000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -297561000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 181431000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Investmentsin Associatesat Cost: 105220000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 0.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 352908000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 42130000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 6136000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 1211333000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 1217469000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 94137000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -430579000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 105220000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 14045000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 4237987000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Net Debt: 2452056000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Net Income: -70593000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -70593000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -70593000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -70593000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -70593000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 53491000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -70593000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Net Interest Income: -211994000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -1680000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -77671000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -336442000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -211994000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -888000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Net PPE: 4493528000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -296574000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 258771000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 4590596000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 410200000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 14045000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 50850000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 585233000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Normalized Income: -70197989.55
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 224500000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Operating Income: 224814000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Operating Revenue: 5197468000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 84652030.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: 700000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 189697000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 15248000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 4520600000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 14656000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 5570000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 209514000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 56104000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 2166000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 46931000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Payable: 128772000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Properties: 119261000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 13401000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 700000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Other Special Charges: 544000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Payables: 1203987000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: -3414000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 10420000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 134717000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Pretax Income: 53491000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -1680000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -299207000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 786576000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 3906077000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 321254000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 804000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 804000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -430579000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Research And Development: 89192000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 918000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 2876488000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 2633000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 38227000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 93206000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Share Issued: 84652030.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 258771000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Short Term Debt Payments: 0.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Special Income Charges: -544000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 4605252000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 4590596000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -148989.55
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Tax Provision: 14650000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.27
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 165216000.00
SMSPHARMA.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -46000000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Assets: 8796101000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 5816585000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Debt: 2540669000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 4605252000.00
SMSPHARMA.NS income_statement (annual, 2023-03-31) — Total Expenses: 4972654000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 4190849000.00
SMSPHARMA.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 4689615000.00